Spots Global Cancer Trial Database for metastatic neuroendocrine prostate cancer
Every month we try and update this database with for metastatic neuroendocrine prostate cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. | NCT06379217 | Metastatic Neur... | [68Ga]Ga-PSMA-1... [68Ga]GA-DOTA-T... [68Ga]Ga-NeoB [177Lu]Lu-PSMA-... [177Lu]Lu-DOTA-... [177Lu]Lu-NeoB L-Lysine HCl-L-... Gonadotropin-re... GnRH antagonist... Antiemetics & a... Metoclopramide | 18 Years - | Novartis |